3rd Quarter - Termination

BIOMET, INC. for BIOMET, INC.

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
—
Terminated
Sep 30, 2014

No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
3rd Quarter - Termination (this page) Oct 20, 2014 — Replaced
3rd Quarter - Termination Amendment (No Activity) Oct 20, 2014 — Yes

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Medicare Inpatient Prospective Payment System ruling for FY2009 - Provisions related to gainsharing/shared savings programs; S.2221 Transparency in Medical Device Pricing Act of 2007 - all provisions; S.2029 PhysicianPayments Sunshine Act of 2007 -all provisions; H.R. 5605 Physician Payments Sunshine Act of 2008-all provisions; H.R.6381 Medical Device Safety Act of 2008- all provisions related to federal premeptionof state laws with respect to Class III devices;

LobbyistCovered position, as disclosed
WILLIAM C KOLTER —

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 5605 (113th), H.R. 6381 (113th), S. 2221 (113th), S. 2029 (113th)

Medical/Disease Research/Clinical Labs MED

S.3398 Medical Device Safety Act of 2008- all provisions related to federal pre-emption of state laws with respect to Call III devices; S.3408 Comparative Effectiveness Research Act of 2008- all provisions related to establishment of a Health care Comparative Research Institute; and FDA Globalization Act - provisions related to inspection fees and schedules.S. 3408: Comparative Effectiveness Research Act of 2008 - All provisions related to establishment of a Health Care Comparative Research Institute; FDA Globalization Act (draft legislation in House and Senateno bill number yet) - Provisions related to inspection fees and schedules

LobbyistCovered position, as disclosed
WILLIAM C KOLTER —

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE

Bills named: S. 3408 (113th), S. 3398 (113th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.